These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36540988)

  • 1. Multi-objective prioritization of genes for high-throughput functional assays towards improved clinical variant classification.
    Chen Y; Jain S; Zeiberg D; Iakoucheva LM; Mooney SD; Radivojac P; Pejaver V
    Pac Symp Biocomput; 2023; 28():323-334. PubMed ID: 36540988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prioritizing genes for systematic variant effect mapping.
    Kuang D; Truty R; Weile J; Johnson B; Nykamp K; Araya C; Nussbaum RL; Roth FP
    Bioinformatics; 2021 Apr; 36(22-23):5448-5455. PubMed ID: 33300982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assigning credit where it is due: an information content score to capture the clinical value of multiplexed assays of variant effect.
    Ranola JMO; Horton C; Pesaran T; Fayer S; Starita LM; Shirts BH
    BMC Bioinformatics; 2024 Sep; 25(1):295. PubMed ID: 39243022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal framework to resolve variants of uncertain significance in
    Biar CG; Pfeifer C; Carvill GL; Calhoun JD
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches.
    Guidugli L; Shimelis H; Masica DL; Pankratz VS; Lipton GB; Singh N; Hu C; Monteiro ANA; Lindor NM; Goldgar DE; Karchin R; Iversen ES; Couch FJ
    Am J Hum Genet; 2018 Feb; 102(2):233-248. PubMed ID: 29394989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
    Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Categorization of
    Bouwman P; van der Heijden I; van der Gulden H; de Bruijn R; Braspenning ME; Moghadasi S; Wessels LFA; ; Vreeswijk MPG; Jonkers J
    Clin Cancer Res; 2020 Sep; 26(17):4559-4568. PubMed ID: 32546644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A machine learning approach based on ACMG/AMP guidelines for genomic variant classification and prioritization.
    Nicora G; Zucca S; Limongelli I; Bellazzi R; Magni P
    Sci Rep; 2022 Feb; 12(1):2517. PubMed ID: 35169226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining and Reducing Variant Classification Disparities.
    Dawood M; Fayer S; Pendyala S; Post M; Kalra D; Patterson K; Venner E; Muffley LA; Fowler DM; Rubin AF; Posey JE; Plon SE; Lupski JR; Gibbs RA; Starita LM; Robles-Espinoza CD; Coyote-Maestas W; Gallego Romero I
    medRxiv; 2024 Apr; ():. PubMed ID: 38645101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance.
    Soens ZT; Branch J; Wu S; Yuan Z; Li Y; Li H; Wang K; Xu M; Rajan L; Motta FL; Simões RT; Lopez-Solache I; Ajlan R; Birch DG; Zhao P; Porto FB; Sallum J; Koenekoop RK; Sui R; Chen R
    Hum Mutat; 2017 Nov; 38(11):1521-1533. PubMed ID: 28714225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalable approaches for generating, validating and incorporating data from high-throughput functional assays to improve clinical variant classification.
    Padigepati SR; Stafford DA; Tan CA; Silvis MR; Jamieson K; Keyser A; Nunez PAC; Nicoludis JM; Manders T; Fresard L; Kobayashi Y; Araya CL; Aradhya S; Johnson B; Nykamp K; Reuter JA
    Hum Genet; 2024 Aug; 143(8):995-1004. PubMed ID: 39085601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.
    Karbassi I; Maston GA; Love A; DiVincenzo C; Braastad CD; Elzinga CD; Bright AR; Previte D; Zhang K; Rowland CM; McCarthy M; Lapierre JL; Dubois F; Medeiros KA; Batish SD; Jones J; Liaquat K; Hoffman CA; Jaremko M; Wang Z; Sun W; Buller-Burckle A; Strom CM; Keiles SB; Higgins JJ
    Hum Mutat; 2016 Jan; 37(1):127-34. PubMed ID: 26467025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of renovo predictions on variants reclassified over time.
    Bonetti E; Tini G; Mazzarella L
    J Transl Med; 2024 Jul; 22(1):713. PubMed ID: 39085881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
    Reuter C; Chun N; Pariani M; Hanson-Kahn A
    J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assigning credit where it's due: An information content score to capture the clinical value of Multiplexed Assays of Variant Effect.
    Ranola JMO; Horton C; Pesaran T; Fayer S; Starita LM; Shirts BH
    bioRxiv; 2023 Oct; ():. PubMed ID: 37905042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
    Lindor NM; Guidugli L; Wang X; Vallée MP; Monteiro AN; Tavtigian S; Goldgar DE; Couch FJ
    Hum Mutat; 2012 Jan; 33(1):8-21. PubMed ID: 21990134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.